Treatment of metastatic adenocarcinoma of the pelvis and the extremities

Journal of Bone and Joint Surgery

Volumn 79, Issue 6, 1997, Pages 917-933

  Aaron, Alan D ^a  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; BISPHOSPHONIC ACID DERIVATIVE; CLODRONIC ACID; ETIDRONIC ACID; MEDRONATE TECHNETIUM TC 99M; PAMIDRONIC ACID; PLACEBO; RADIOISOTOPE; RHENIUM 186; SAMARIUM 153; STRONTIUM 89;

BONE METASTASIS; BONE PAIN; BONE SCINTISCANNING; CANCER RADIOTHERAPY; CLINICAL FEATURE; CLINICAL TRIAL; FRACTURE FIXATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIMB TUMOR; NEEDLE BIOPSY; ORAL DRUG ADMINISTRATION; PATHOLOGIC FRACTURE; PELVIS CANCER; PRIORITY JOURNAL; REVIEW;

EID: 0030981161     PISSN: 00219355     EISSN: None     Source Type: Journal    
DOI: 10.2106/00004623-199706000-00018     Document Type: Review

References (130)

1. Adami, S., and Mian, M.: Clodronate therapy of metastatic bone disease in patients with prostatic carcinoma. In Bisphosphonates and Tumor Osteolysis. Recent Results in Cancer Research, pp. 67-72. Edited by K. W. Brunner, B. H. Fleisch, and H.-J. Senn. New York, Springer, 1989.
2. Adams, J. E., and Isherwood, I.: Conventional and new techniques in radiological diagnosis. In Bone Metastasis: Monitoring and Treatment, pp. 107-148. Edited by B. A. Stoll and S. Parbhoo. New York, Raven Press, 1983.
3. Albright, J. A.; Gillespie, T. E.: and Butaud, T. R.: Treatment of bone metastases. Sem. Oncol., 7:418-434, 1980.
4. Ascari, E.; Attardo-Parrinello, G.; and Merlini, G.: Treatment of painful bone lesions and hypercalcemia. European J. Haematol., Supplementum 51, pp. 135-139, 1989.
5. 32P therapy and sequential hemibody irradiation (HBI) for bone metastases as methods of whole body irradiation. Am. J. Clin. Oncol., 9: 264-268, 1986.
6. Barichello, M.; Gion, M.; Bonazza, A.; Delli Ponti, U. S.; Bolgan, A.; Contemori, G. P.; Barioli, P.; Capitanio, G.; Pecori, B.; Omacini, S.; Benvegnu, L.; and Petracco, S.: Prostate-specific antigen as a unique routine test in monitoring therapy for inoperable prostate cancer: comparison with radionuclide bone scan and prostatic acid phosphatase. European Urol., 27: 295-300, 1995.
7. Bayard, S.; Greenberg, R.; Showalter, D.; and Byar, D.: Comparison of treatments for prostatic cancer using an exponential-type life model relating survival to concomitant information. Cancer Chemother: Rep.-Part 1, 58: 845-859, 1974.
8. Bayouth, J. E.; Macey, D. J.; Kasi, L. P.; and Fossella, F. V.: Dosimetry and toxicity of samarium-153-EDTMP administered for bone pain due to skeletal metastases. J. Nucl. Med., 35: 63-69, 1994.
9. Beals, R. K.; Lawton, G. D.; and Snell, W. E.: Prophylactic internal fixation of the femur in metastatic breast cancer. Cancer, 28: 1350-1354, 1971.
10. Blake, G. M.: Zivanovic, M. A.; McEwan, A. J.; and Ackery, D. M.: Sr-89 therapy: strontium kinetics in disseminated carcinoma of the prostate. European J. Nucl. Med., 12: 447-454, 1986.
11. Bolger, J. J.; Dearnaley, D. P.; Kirk, D.; Lewington, V. J.; Mason, M. D.; Quilty, P. M.; Reed, N. S.: Russell, J. M.; and Yardley, J.: Strontium-89 (Metastron) versus external beam radiotherapy in patients with painful bone metastases secondary to prostate cancer: preliminary report of a multicenter trial. UK Metastron Investigators Group. Sem. Oncol., 20 (3 Supplement 2): 32-33, 1993.
12. Bonica, J. J.; Ventafridda, V.; and Twycross, R. G.: Cancer pain. In The Management of Pain, edited by J. J. Bonica. Ed. 2, vol. 1, pp. 400-460. Philadelphia, Lea and Febiger, 1990.
13. Brown, A. P.; Greening, W. P.; McCready, V. R.; Shaw, H. J.; and Harner, C. L.: Radioiodine treatment of metastatic thyroid carcinoma: the Royal Marsden Hospital experience. British J. Radiol., 57: 323-327, 1984.
14. Byrne, T. N.: Spinal cord compression from epidural metastases. New England J. Med., 327: 614-619, 1992.
15. Cheng, D. S.; Seitz, C. B.; and Eyre, H. J.: Nonoperative management of femoral, humeral, and acetabular metastases in patients with breast carcinoma. Cancer, 45: 1533-1537, 1980.
16. Chin, H.-C.; Frassica, F. J.; Hein, T. J.; Shives, T. C.; Pritchard, D. J.; Sim, F. H.; and Chao, E. Y. S.: Metastatic diaphyseal fractures of the shaft of the humerus. The structural strength evaluation of a new method of treatment with a segmental defect prosthesis. Clin. Orthop., 248: 231-239, 1989.
17. Chung, T. S.: Metastatic malignancy to the bones of the hand. J. Surg. Oncol., 24: 99-102, 1983.
18. Coleman, R. E.; Houston, S.; James, I.; Rodger, A.; Rubens, R. D.; Leonard, R. C.; and Ford, J.: Preliminary results of the use of urinary excretion of pyridinium crosslinks for monitoring metastatic bone disease. British J. Cancer, 65: 766-768, 1992.
19. Conroy, T.; Malissard, L.; Dartois, D.; Luporsi, E.; Stines, J.; and Chardot, C.: Histoire naturelle et evolution des metastases osseuses. Appropos des 429 observations. Bull. Cancer (Paris), 75: 845-857, 1988.
20. Coombes, R. C.; Powles, T. J.; Gazet, J. C.; Nash, A. G.; Ford, H. T.; McKinna, A.; and Neville, A. M.: Assessment of biochemical tests to screen for metastases in patients with breast cancer. Lancet, 1: 296-297, 1980.
21. Crowninshield, R. D.; Johnston, R. C.; Andrews, J. G.; and Brand, R. A.: A biomechanical investigation of the human hip. J. Biomech., 11: 75-85, 1978.
22. Curley, T.; Scher, H.; and Thaler, H.: Rhenium (Re-186-HEDP) for palliation of painful bone metastases from prostatic cancer (PC). Proc. Am. Soc. Clin. Oncol., 10: 347, 1991.
23. Damron, T. A.; Heiner, J. P.; Freund, E. M. N.; Damron, L. A.; McCabe, R.; and Vanderby, R.: A biomechanical analysis of prophylactic fixation for pathological fractures of the distal third of the humerus. J. Bone and Joint Surg., 76-A: 839-847, June 1994.
24. Douglas, H. O.; Shukla, S. K.; and Mindell, E.: Treatment of pathological fractures of long bones excluding those due to breast cancer. J. Bone and Joint Surg., 58-A: 1055-1061, Dec. 1976.
25. Edelstyn, G. A.; Gillespie, P. J.; and Grebbell, F. S.: The radiological demonstration of osseous metastases. Experimental observations. Clin. Radiol., 18: 158-162, 1967.
26. Elomaa, L.; Blomqvist, C.; Grohn, P.; Porkka, L.; Kairento, L.; Selander, K.; Lamberg-Allardt, C.; and Holmstrom, T.: Long-term controlled trial with diphosphonate in patients with osteolytic bone metastases. Lancet, 1: 146-149, 1983.
27. Eyre, D. R.; Koob, T. J.; and Van Ness, K. P.: Quantitation of hydroxypyridinium crosslinks in collagen by high-performance liquid chromatography. Anal. Biochem., 137: 380-388, 1984.
28. Fidler, M.: Incidence of fracture through metastases in long bones. Acta Orthop. Scandinavica, 52: 623-627, 1981.
29. Fleisch, H.: Bisphosphonates. Pharmacology and use in the treatment of tumour-induced hypercalcaemic and metastatic bone disease. Drugs, 42: 919-944, 1991.
30. Flemming, J. E., and Beals, R. K.: Pathologic fracture of the humerus. Clin. Orthop., 203: 258-260, 1986.
31. Foley, K. M.: The treatment of cancer pain. New England J. Med., 313: 84-95, 1985.
32. Fornasier, V. L., and Horne, J. G.: Metastases to the vertebral column. Cancer. 36: 590-594, 1975.
33. Freitas, J. E.; Gilvydas, R.; Ferry, J. D.; and Gonzalez, J. A.: The clinical utility of prostate-specific antigen and bone scintigraphy in prostate cancer follow-up. J. Nucl. Med., 32: 1387-1390, 1991.
34. Gainor, B. J., and Buchert, P.: Fracture healing in metastatic bone disease. Clin. Orthop., 178: 297-302, 1983.
35. Galasko, C. S.: The detection of skeletal metastases from mammary cancer by gamma camera scintigraphy. British J. Surg., 56: 757-764, 1969.
36. Galasko, C. S.: Skeletal metastases and mammary cancer. Ann. Roy. Coll. Surg., 50: 3-28, 1972.
37. Galasko, C. S. B.: Development of skeletal metastases. In Skeletal Metastases, pp. 22-51. Edited by C. S. B. Galasko. Boston, Butterworth, 1986.
38. Galasko, C. S., and Sylvester, B. S.: Back pain in patients treated for malignant tumours. Clin. Oncol., 4: 273-283, 1978.
39. Goris, M. L., and Bretille, J.: Skeletal scintigraphy for the diagnosis of malignant metastatic disease to the bones. Radiother. and Oncol., 3: 319-329, 1985.
40. Habermann, E. T.; Sachs, R.; Stern, R. E.; Hirsh, D. M.; and Anderson, W. J., Jr.: The pathology and treatment of metastatic disease of the femur. Clin. Orthop., 169: 70-82, 1982.
41. Harrington, K. D.: The management of malignant pathologic fractures. In Instructional Course Lectures, The American Academy of Orthopaedic Surgeons. Vol. 26, pp. 147-162. St. Louis, C. V. Mosby, 1977.
42. Harrington, K. D.: The management of acetabular insufficiency secondary to metastatic malignant disease. J. Bone and Joint Surg., 63-A: 653-664, April 1981.
43. Harrington, K. D.: Introduction. In Orthopaedic Management of Metastatic Bone Disease, pp. 1-14. Edited by K. D. Harrington. St. Louis, C. V. Mosby, 1988.
44. Harrington, K. D.: Orthopaedic management of extremity and pelvic lesions. Clin. Orthop., 312: 136-147, 1995.
45. Harrington, K. D.; Sim, F. U.; Enis, J. E.; Johnston, J. O.; Dick, H. M.; and Gristina, A. G.: Methylmethacrylate as an adjunct in internal fixation of pathological fractures. Experience with three hundred and seventy-five cases. J. Bone and Joint Surg., 58-A: 1047-1055, Dec. 1976.
46. Healey, J. H.; Turnbull, A. D. M.; Miedema, B.; and Lane, J. M.: Acrometastases. A study of twenty-nine patients with osseous involvement of the hands and feet. J. Bone and Joint Surg., 68-A: 743-746, June 1986.
47. Heim, H. M., and Oei, T. P.: Comparison of prostate cancer patients with and without pain. Pain, 53: 159-162, 1993.
48. Higinbotham, N. L., and Marcove, R. C.: The management of pathological fractures. J. Trauma, 5: 792-798, 1965.
49. Hipp, J. A.; Rosenberg, A. E.; and Hayes, W. C.: Mechanical properties of trabecular bone within and adjacent to osseous metastases. J. Bone and Min. Res., 7: 1165-1171, 1992.
50. Hipp, J. A.; Springfield, D. S.; and Hayes, W. C.: Predicting pathologic fracture risk in the management of metastatic bone defects, Clin. Orthop., 312: 120-135, 1995.
51. Hipp, J. A.; Edgerton, B. C.; An, K.-N.; and Hayes, W. C.: Structural consequences of transcortical holes in long bones loaded in torsion. J. Biomech., 23: 1261-1268, 1990.
52. Hipp, J. A.; McBroom, R. J.; Cheal, E. J.; and Hayes, W. C.: Structural consequences of endosteal metastatic lesions in long bones. J. Onthop. Res., 7: 828-837, 1989.
53. Hopkins, S. C.; Nissenkorn, I.; Palmieri, G. M.; Ikard, M.; Moinuddin, M.; and Soloway, M. S.: Serial spot hydroxyproline/creatinine ratios in metastatic prostate cancer. J. Urol., 129: 319-323, 1983.
54. Hortobagyi, G. N.; Theriault, R. L.; Porter, L.; Blayney, D.; Lipton, A.; Sinoff, C.; Wheeler, H.; Simeone, J. F.; Seaman, J.; Knight, R. D.; Heffernan, M.; and Reitsma, D. J.: Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group. New England J. Med., 335: 1785-1791, 1996.
55. Hoskin, P. J.: Scientific and clinical aspects of radiotherapy in the relief of bone pain. Cancer Surg., 7: 69-86, 1988.
56. Hoskin, P. J.; Price, P.; Easton, D.; Regan, J.; Austin, D.; Palmer, S.; and Yarnold, J. R.: A prospective randomised trial of 4 Gy or 8 Gy single doses in the treatment of metastatic bone pain. Radiother. and Oncol., 23: 74-78, 1992.
57. Hudson, M. A.; Bahnson, R. R.: and Catalona, W. J.: Clinical use of prostate specific antigen in patients with prostate cancer. J. Urol., 142: 1011-1017, 1989.
58. Keene, J. S.; Sellinger, D. S.; McBeath, A. A.; and Engber, W. D.: Metastatic breast cancer in the femur. A search for the lesion at risk of fracture. Clin. Orthop., 203: 282-288, 1986.
59. Kim, S. I.; Chen, D. C.; and Muggia, F. M.: A new look at radionuclides therapy in metastatic disease of bone (review and prospects). Anticancer Res., 8: 681-684, 1988.
60. Koenders, P. G.; Beex, L. V.; Kloppenborg, P. W.; Smals, A. G.; and Benraad, T. J.: Human breast cancer: survival from first metastasis. Breast Cancer Study Group. Breast Cancer Res. and Treat., 21: 173-180, 1992.
61. Koizumi, M.; Yamada, Y.; Takiguchi, T.; Nomura, E.; Furukawa, M.; Kitahara, T.; Yamashita, T.; Maeda, H.; Takahashi, S.; Aiba, K.; and Ogata, E.: Bone metabolic markers in bone mtastases. J. Cancer Res. and Clin. Oncol., 121: 542-548, 1995.
62. Laing, A. H.; Ackery, D. M.; Bayly, R. J.; Buchanan, R. B.; Lewington, V. J.; McEwan, A. J.; Macleod, P. M.; and Zivanovic, M. A.: Strontium-89 chloride for pain palliation in prostatic skeletal malignancy. British J. Radiol., 64: 816-822, 1991.
63. Lane, J. M.; Sculco, T. P.; and Zolan, S.: Treatment of pathological fractures of the hip by endoprosthetic replacement. J. Bone and Joint Surg., 62-A: 954-959, Sept. 1980.
64. Lewallen, R. P.; Pritchard, D. J.; and Sim, F. H.: Treatment of pathologic fractures or impending fractures of the humerus with Rush rods and methylmethacrylate. Experience with 55 cases in 54 patients, 1968-1977. Clin. Onthop., 166: 193-198, 1982.
65. Lewington, V. J.; McEwan, A. J.; Ackery, D. M.; Bayly, R. J.; Keeling, D. H.; Macleod, P. M.; Porter, A. T.; and Zivanovic, M. A.: A prospective, randomised double-blind crossover study to examine the efficacy of strontium-89 in pain palliation in patients with advanced prostate cancer metastatic to bone. European J. Cancer, 27: 954-958, 1991.
66. Lote, K.; Walloe, A.; and Bjersand, A.: Bone metastasis. Prognosis, diagnosis and treatment. Acta Radiol.-Oncol., 25: 227-232, 1986.
67. McBroom, R. J.; Cheal, E. J.; and Hayes, VV. C.: Strength reductions from metastatic cortical defects in long bones. J. Orthop. Res., 6: 369-378, 1988.
68. McNeil, B. J.: Value of bone scanning in neoplastic disease. Sem. Nucl. Med., 14: 277-286, 1984.
69. Mankin, H. J.; Lange, T. A.; and Spanier, S. S.: The hazards of biopsy in patients with malignant primary bone and soft-tissue tumors. J. Bone and Joint Surg., 64-A: 1121-1127, Oct. 1982.
70. Mankin, H. J.; Mankin, C. J.; and Simon, M. A.: The hazards of the biopsy, revisited. For the members of the Musculoskeletal Tumor Society. J. Bone and Joint Surg., 78-A: 656-663, May 1996.
71. Maxon, H. R.; Deutsch, E. A.; Thomas, S. R.; Libson, K.; Lukes, S. J.; Williams, C. C.; and Ali, S.: Re-186(Sn) HEDP for treatment of multiple metastatic foci in bone: human biodistribution and dosimetric studies. Radiology, 166: 501-507, 1988.
72. Maxon, H. R., III; Schroder, L. E.; Thomas, S. R.; Hertzberg, V. S.; Deutsch, E. A.; Scher, H. I.; Samaratunga, R. C.; Libson, K. F.; Williams, C. C.; Moulton, J. S.; and Schneider, H. J.: Re-186(Sn) HEDP for treatment of painful osseous metastases: initial clinical experience in 20 patients with hormone-resistant prostate cancer. Radiology, 176: 155-159, 1990.
73. Melkko, J.; Niemi, S.; Risteli, L.; and Risteli, J.: Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen. Clin. Chem., 36: 1328-1332, 1990.
74. Mertens, W. C.: Radionuclide therapy of bone metastases: prospects for enhancement of therapeutic efficacy. Sem. Oncol., 20 (3 Supplement 2): 49-55, 1993.
75. Mickelson, M. R., and Bonfiglio, M.: Pathological fractures in the proximal part of the femur treated by Zickel-nail fixation. J. Bone and Joint Surg., 58-A: 1067-1070, Dec. 1976.
76. Miller, P. D.; Eardley, I.; and Kirby, R. S.: Prostate specific antigen and bone scan correlation in the staging and monitoring of patients with prostatic cancer. British J. Urol., 70: 295-298, 1992.
77. Mirels, H.: Metastatic disease in long bones. A proposed scoring system for diagnosing impending pathologic fractures. Clin. Orthop., 249: 256-264, 1989.
78. Mithal, N. P.; Needham, P. R.; and Hoskin, P. J.: Retreatment with radiotherapy for painful bone metastases. Internat. J. Radiat. Oncol., Biol., Phys., 29: 1011-1014, 1994.
79. Murray, J. A.; Bruels, M. C.; and Lindberg, R. D.: Irradiation of polymethylmethacrylate. In vitro gamma radiation effect. J. Bone and Joint Surg., 56-A: 311-312, March 1974.
80. Namer, M.: Clinical consequences of osteolytic bone metastases. Bone, 12 (Supplement 1): 7S, 1991.
81. Nesbit, R. M., and Baum, W. C.: Endocrine control of prostatic carcinoma: clinical and statistical survey of 1818 cases. J. Am. Med. Assn., 143: 471-482, 1984.
82. Nielsen, O. S.; Munro, A. J.; and Tannock, I. F.: Bone metastases: pathophysiology and management policy. J. Clin. Oncol., 9: 509-524, 1991.
83. Nystrom, J. S.; Weiner, J. M.; Wolf, R. M.; Bateman, J. R.; and Viola, M. V.: Identifying the primary site in metastatic cancer of unknown origin. Inadequacy of roentgenographic procedures. J. Am. Med. Assn., 241: 381-383, 1979.
84. Oda, M. A. S., and Shurman, D. J.: Monitoring of pathological fracture. In Bone Metastasis: Monitoring and Treatment, pp. 271-287. Edited by B. A. Stoll and S. Parbhoo. New York, Raven Press, 1983.
85. Oesterling, J. E.; Martin, S. K.; Bergstralh, E. J.; and Lowe, F. C.: The use of prostate-specific antigen in staging patients with newly diagnosed prostate cancer. J. Am. Med. Assn., 269: 57-60, 1993.
86. O'Rourke, N.; McCloskey, E.; Houghton, F.; Huss, H.; and Kanis, J. A.: Double-blind, placebo-controlled, dose-response trial of oral clodronate in patients with bone metastases. J. Clin. Oncol., 13: 929-934, 1995.
87. Parrish, F. F., and Murray, J. A.: Surgical treatment for secondary neoplastic fractures. A retrospective study of ninety-six patients. J. Bone and Joint Surg., 52-A: 665-686, June 1970.
88. Paterson, A. H.; Powles, T. J.; Kanis, J. A.; McCloskey, E.; Hansen, J.; and Ashley, S.: Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer. J. Clin. Oncol., 11: 59-65, 1993.
89. Patriarco, A. G.; Mann, R. W.; Simon, S. R.; and Mansour, J. M.: An evaluation of the approaches of optimization models in the prediction of muscle forces during human gait. J. Biomech., 14: 513-525, 1981.
90. Patterson, B. M.; Healey, J. H.; Cornell, C. N.; and Sharrock, N. E.: Cardiac arrest during hip arthroplasty with a cemented long-stem component. A report of seven cases. J. Bone and Joint Surg., 73-A: 271-277, Feb. 1991.
91. Perez, D. J.; Powles, T. J.; Milan, J.; Gazet, J. C.; Ford, H. T.; McCready, V. R.; MacDonald, J. S.; and Coombes, R. C.: Detection of breast carcinoma metastases in bone: relative merits of x-rays and skeletal scintigraphy. Lancet, 2: 613-616, 1983.
92. Price, P.; Hoskin, P. J.; Easton, D.; Austin, D.; Palmer, S. G.; and Yarnold, J. R.: Prospective randomised trial of single and multifraction radiotherapy schedules in the treatment of painful bone metastases. Radiother. and Oncol., 6: 247-255, 1986.
93. Pugh, J.; Sherry, H. S.; Futterman, B.; and Frankel, V. H.: Biomechanics of pathologic fractures. Clin. Orthop., 169: 109-114, 1982.
94. Reale, M. G.; Santini, D.; Marchei, G. G.; Manna, A.; Del Nero, A.; Bianco, V.; Marchei, P.; and Frati, L.: Skeletal alkaline phosphatase as a serum marker of bone metastases in the follow-up of patients with breast cancer. Internat. J. Biol. Markers. 10: 42-46, 1995.
95. Redmond, B. J.; Biermann, J. S.; and Blasier, R. B.: Interlocking intramedullary nailing of pathological fractures of the shaft of the humerus. J. Bone anid Joint Surg., 78-A: 891-896, June 1996.
96. Risteli, J.; Elomaa, I.; Niemi, S.; Novamo, A.; and Risteli, L.: Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: a new serum marker of bone collagen degradation. Clin. Chem., 39: 635-640, 1993.
97. Robinson, R. G.; Blake, G. M.; Preston, D. F.; McEwan, A. J.; Spicer, J. A.; Martin, N. L.; Wegst, A. U.; and Ackery, D. M.: Strontium-89: treatment results and kinetics in patients with painful metastatic prostate and breast cancer in bone. Radiographics, 9: 271-281, 1989.
98. Rougraff, B. T.; Kneisl, J. S.; and Simon, M. A.: Skeletal metastases of unknown origin. A prospective study of a diagnostic strategy. J. Bone and Joint Surg., 75-A: 1276-1281, Sept. 1993.
99. Ryan, J. R., and Begeman, P. C.: The effects of filling experimental large cortical defects with methylmethacrylate. Clin. Orthop., 185: 306-310, 1984.
100. Ryan, J. R.; Rowe, D. E.; and Salciccioli, G. G.: Prophylactic internal fixation of the femur for neoplastic lesions. J. Bone and Joint Surg., 58-A: 1071-1074, Dec. 1976.
101. Salazar, O. M.; Rubin, P.; Hendrickson, F. R.; Komaki, R.; Poulter, C.; Newall, J.; Asbell, S. O.; Mohiuddin, M.; and Van Ess, J.: Single-dose half-body irradiation for palliation of multiple bone metastases from solid tumors. Final Radiation Therapy Oncology Group report. Cancer, 58: 29-36, 1986.
102. Schaffer, D. L., and Pendergrass, H. P.: Comparison of enzyme, clinical, radiographic, and radionuclide methods of detecting bone metastases from carcinoma of the prostate. Radiology, 121: 431-434, 1976.
103. Scher, H. I., and Chung, L. W.: Bone metastases: improving the therapeutic index. Sem. Oncol., 21: 630-656, 1994.
104. Scher, H. I., and Yagoda, A.: Bone metastases: pathogenesis, treatment, and rationale for use of resorption inhibitors. Am. J. Med., 82: 6-28, 1987.
105. Scher, H.; Curley, T.; Graham, M.; Yeh, S.; Liebertz, C.; Kelly, W.; and Larson, S.: Phase I trial of escalated dose of rhenium-186-hydroxyethylidene diphosphonate (RE-186-HEDP) in patients (PTS) with metastatic prostate cancer (PC) to bone [abstract]. Proc. Am. Assn. Clin. Oncol., 13: 242, 1944.
106. Schurman, D. J., and Amstutz, H. C.: Orthopedic management of patients with metastatic carcinoma of the breast. Surg., Gynic. and Obstet., 137: 831-836, 1973.
107. Sim, F. H., and Chao, E. Y. S.: Bone loss in the proximal femur: proximal femoral replacement. In Joint Replacement Arthroplasty, pp. 820-833. Edited by B. Morrey. New York, Churchill Livingstone, 1991.
108. Sim, F. H., and Pritchard, D. J.: Metastatic disease in the upper extremity. Clin. Orthop., 169: 83-94, 1982.
109. Sim, F. H.; Frassica, F. J.; and Chao, E. Y. S.: Orthopaedic management using new devices and prostheses. Clin. Orthop., 312: 160-172, 1995.
110. Sim, F. H.; Edmonson, J. H.; Mcleod, R. A.; and Unni, K. K.: Metastatic bone disease. In Diagnosis and Treatment of Bone Tumors: A Team Approach (a Mayo Clinic Monograph), pp. 259-278. Edited by F. H. Sim. Thorofare, New Jersey, Slack, 1983.
111. Simon, M. A.: Current concepts review. Biopsy of musculoskeletal tumors. J. Bone and Joint Surg., 64-A: 1253-1257, Oct. 1982.
112. Simon, M. A., and Finn, H. A.: Diagnostic strategy for bone and soft-tissue tumors. In Instructional Course Lectures, The American Academy of Orthopaedic Surgeons. Vol. 43, pp. 527-536. Rosemont, Illinois, The American Academy of Orthopaedic Surgeons, 1994.
113. Smith, J. A., Jr.: Palliation of painful bone metastases from prostate cancer using sodium etidronate: results of a randomized, prospective, double-blind, placebo-controlled study. J. Urol., 141: 85-87, 1989.
114. Stoll, B. A.: Natural history, prognosis, and staging of the bone metastases. In Bone Metastasis: Monitoring and Treatment, pp. 1-20. Edited by B. A. Stoll and S. Parbhoo. New York, Raven Press, 1983.
115. Tofe, A. J.; Francis, M. D.; and Harvey, W. J.: Correlation of neoplasms with incidence and localization of skeletal metastasis: an analysis of 1,355 diphosphonate bone scans. J. Nucl. Med., 16: 986-989, 1975.
116. Tong, D.; Gillick, L.; and Hendrickson, F. R.: The palliation of symptomatic osseous metastases: final results of the study by the Radiation Therapy Oncology Group. Cancer, 50: 893-899, 1982.
117. Turner, J. H.; Claringbold, P. G.; Hetherington, E. L.; Sorby, P.; and Martindale, A. A.: A phase I study of samarium-153 ethylenediaminetetramethylene phosphorate therapy for disseminated skeletal metastases. J. Clin. Oncol., 7: 1926-1931, 1989.
118. Tursky, B.: The development of a pain perception profile: a psychophysical approach. In Pain. New Perspectives in Therapy and Research, pp. 171-194. Edited by M. Weisenberg and B. Tursky. New York, Plenum Press, 1976.
119. Twycross, R. G.: Analgesics and relief of bone pain. In Bone Metastasis: Monitoring and Treatment, pp. 289-310. Edited by B. A. Stoll and S. Parbhoo. New York, Raven Press, 1983.
120. Twycross, R. G.: Management of pain in skeletal metastases. Clin. Orthop., 312: 187-196, 1995.
121. Vail, T. P., and Harrelson, J. M.: Treatment of pathologic fracture of the humerus. Clin. Orthop., 268: 197-202, 1991.
122. van Holten-Verzantvoort, A. T.; Bijvoet, O. L.; Cleton, F. J.; Hermans, J.; Kroon, H. M.; Harinck, H. I.; Vermey, P.; Elte, J. W.; Neijt, J. P.; Beex, L. V.; and Blijham, G.: Reduced morbidity from skeletal metastases in breast cancer patients during long-term bisphosphonate (APD) treatment. Lancet, 2: 983-985, 1987.
123. van Holten-Verzantvoort, A. T. M.; Kroon, H. M.; Bijvoet, O. L. M.; Cleton, F. J.; Beex, L. V. A.; Blijham, G.; Hermans, J.; Neijt, J. P.; Papapoulos, S. E.; Sleeboom, H. P.; Vermey, P.; and Zwinderman, A. H.: Palliative pamidronate treatment in patients with bone metastases from breast cancer. J. Clin. Oncol., 11: 491-498, 1993.
124. Wilner, D.: Cancer metastasis to bone. In Radiology of Bone Tumors and Allied Disorders, edited by D. Wilner. Vol. 4, pp. 3641-3908. Philadelphia, W. B. Saunders, 1982.
125. Winchester, D. P.; Sener, S. F.; Khandekar, J. D.; Oviedo, M. A.; Cunningham, M. P.; Caprini, J. A.; Burkett, F. E.; and Scanlon, E. F.: Symptomatology as an indicator of recurrent or metastatic breast cancer. Cancer, 43: 956-960, 1979.
126. Wingo, P. A.; Tong, T.; and Bolden, S.: Cancer statistics, 1995. CA: Cancer J. Clinicians, 45: 8-30, 1995.
127. Wu, K. K., and Guise, E. R.: Metastatic tumors of the hand: report of six cases. J. Hand Surg., 3: 271-276, 1978.
128. Yazawa, Y.; Frassica, F. J.; Chao, E. Y. S.; Pritchard, D. J.; Sim, F. H.; and Shives, T. C.: Metastatic bone disease. A study of the surgical treatment of 166 pathologic humeral and femoral fractures. Clin. Orthop., 251: 213-219, 1990.
129. Zaninotto, M.; Secchiero, S.; Rubin, D.; Sciacovelli, L.; Trovo, M.; Bortolus, R.; and Plebani, M.: Serum bone alkaline phosphatase in the follow-up of skeletal metastases. Anticancer Res., 15: 2223-2228, 1995.
130. Zickel, R. E., and Mouradian, W. H.: Intramedullary fixation of pathological fractures and lesions of the subtrochanteric region of the femur. J. Bone and Joint Surg., 58-A: 1061-1066, Dec. 1976.